195 related articles for article (PubMed ID: 35732460)
1. NOD/RIPK2 signalling pathway contributes to osteoarthritis susceptibility.
Jurynec MJ; Gavile CM; Honeggar M; Ma Y; Veerabhadraiah SR; Novak KA; Hoshijima K; Kazmers NH; Grunwald DJ
Ann Rheum Dis; 2022 Oct; 81(10):1465-1473. PubMed ID: 35732460
[TBL] [Abstract][Full Text] [Related]
2. A hyperactivating proinflammatory RIPK2 allele associated with early-onset osteoarthritis.
Jurynec MJ; Sawitzke AD; Beals TC; Redd MJ; Stevens J; Otterud B; Leppert MF; Grunwald DJ
Hum Mol Genet; 2018 Jul; 27(13):2383-2391. PubMed ID: 29659823
[TBL] [Abstract][Full Text] [Related]
3. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.
Nachbur U; Stafford CA; Bankovacki A; Zhan Y; Lindqvist LM; Fiil BK; Khakham Y; Ko HJ; Sandow JJ; Falk H; Holien JK; Chau D; Hildebrand J; Vince JE; Sharp PP; Webb AI; Jackman KA; Mühlen S; Kennedy CL; Lowes KN; Murphy JM; Gyrd-Hansen M; Parker MW; Hartland EL; Lew AM; Huang DC; Lessene G; Silke J
Nat Commun; 2015 Mar; 6():6442. PubMed ID: 25778803
[TBL] [Abstract][Full Text] [Related]
4. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations.
Marcinek P; Jha AN; Shinde V; Sundaramoorthy A; Rajkumar R; Suryadevara NC; Neela SK; van Tong H; Balachander V; Valluri VL; Thangaraj K; Velavan TP
PLoS One; 2013; 8(8):e73103. PubMed ID: 24015287
[TBL] [Abstract][Full Text] [Related]
6. ASKA technology-based pull-down method reveals a suppressive effect of ASK1 on the inflammatory NOD-RIPK2 pathway in brown adipocytes.
Takayanagi S; Watanabe K; Maruyama T; Ogawa M; Morishita K; Soga M; Hatta T; Natsume T; Hirano T; Kagechika H; Hattori K; Naguro I; Ichijo H
Sci Rep; 2021 Nov; 11(1):22009. PubMed ID: 34759307
[TBL] [Abstract][Full Text] [Related]
7. The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease.
Ermann J; Matmusaev M; Haley EK; Braun C; Jost F; Mayer-Wrangowski S; Hsiao P; Ting N; Li L; Terenzio D; Chime J; Lukas S; Patnaude L; Panzenbeck M; Csordas D; Zheng J; Mierz D; Simpson T; King FJ; Klimowicz AP; Mbow ML; Fine JS; Miller CA; Fogal SE; Byrne FR
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G500-G512. PubMed ID: 34494462
[TBL] [Abstract][Full Text] [Related]
8. Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells.
Park JY; Lee TS; Noh EJ; Jang AR; Ahn JH; Kim DY; Jung DH; Song EJ; Lee YJ; Lee YJ; Lee SK; Park JH
Am J Reprod Immunol; 2021 Jul; 86(1):e13403. PubMed ID: 33580557
[TBL] [Abstract][Full Text] [Related]
9. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
10. Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold.
Suebsuwong C; Dai B; Pinkas DM; Duddupudi AL; Li L; Bufton JC; Schlicher L; Gyrd-Hansen M; Hu M; Bullock AN; Degterev A; Cuny GD
Eur J Med Chem; 2020 Aug; 200():112417. PubMed ID: 32505849
[TBL] [Abstract][Full Text] [Related]
11. RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice.
Duggan BM; Cavallari JF; Foley KP; Barra NG; Schertzer JD
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32473019
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
13. Asparagine attenuates hepatic injury caused by lipopolysaccharide in weaned piglets associated with modulation of Toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling and their negative regulators.
Wu H; Liu Y; Pi D; Leng W; Zhu H; Hou Y; Li S; Shi H; Wang X
Br J Nutr; 2015 Jul; 114(2):189-201. PubMed ID: 26079268
[TBL] [Abstract][Full Text] [Related]
14. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.
Vieira SM; Cunha TM; França RF; Pinto LG; Talbot J; Turato WM; Lemos HP; Lima JB; Verri WA; Almeida SC; Ferreira SH; Louzada-Junior P; Zamboni DS; Cunha FQ
J Immunol; 2012 May; 188(10):5116-22. PubMed ID: 22491249
[TBL] [Abstract][Full Text] [Related]
15. RIPK2 as a promising druggable target for autoimmune diseases.
Zhao W; Leng RX; Ye DQ
Int Immunopharmacol; 2023 May; 118():110128. PubMed ID: 37023697
[TBL] [Abstract][Full Text] [Related]
16. RIPK2 polymorphisms and susceptibility to tuberculosis in a Western Chinese Han population.
Song J; Liu T; Jiao L; Zhao Z; Hu X; Wu Q; Bai H; Lv M; Meng Z; Wu T; Chen H; Chen X; Song X; Ying B
Infect Genet Evol; 2019 Nov; 75():103950. PubMed ID: 31279003
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
[TBL] [Abstract][Full Text] [Related]
18. Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling.
Nikhar S; Siokas I; Schlicher L; Lee S; Gyrd-Hansen M; Degterev A; Cuny GD
Eur J Med Chem; 2021 Apr; 215():113252. PubMed ID: 33601309
[TBL] [Abstract][Full Text] [Related]
19. Expression and activity of NOD1 and NOD2/RIPK2 signalling in mononuclear cells from patients with rheumatoid arthritis.
Franca R; Vieira SM; Talbot J; Peres RS; Pinto LG; Zamboni DS; Louzada-Junior P; Cunha FQ; Cunha TM
Scand J Rheumatol; 2016 Jan; 45(1):8-12. PubMed ID: 26202066
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.
Tigno-Aranjuez JT; Benderitter P; Rombouts F; Deroose F; Bai X; Mattioli B; Cominelli F; Pizarro TT; Hoflack J; Abbott DW
J Biol Chem; 2014 Oct; 289(43):29651-64. PubMed ID: 25213858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
